PVI
WGS icon

Pura Vida Investments’s GeneDx Holdings WGS Stock Holding History

Pura Vida Investments’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,000
Closed -$261K – 64
2024
Q2 		$261K Buy
+10,000
New +$190K 0.17% 47
2021
Q1 		– Sell
-7,273
Closed -$2.65M – 262
2020
Q4 		$2.65M Buy
+7,273
New +$2.53M 0.1% 131

Other funds holding WGS

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Corvex Management
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $39B AUM 18.55% 1-Year Est. Return

Pura Vida Investments's WGS Position: Q3 2024 in Review

Pura Vida Investments sold out of GeneDx Holdings (WGS) in Q3 2024, closing a stake of 10,000 shares — an estimated $261K sold.

Pura Vida Investments first reported a position in WGS in Q4 2020 and held it in 2 quarters. The position peaked at $2.65M in Q4 2020. 136 funds tracked by Wall St. Rank hold WGS as of Q3 2024.

  • Pura Vida Investments reported no remaining GeneDx Holdings position as of Q3 2024 after selling out during the quarter.
  • Pura Vida Investments sold 10,000 GeneDx Holdings shares in Q3 2024, an estimated $261K.
  • Pura Vida Investments first reported a position in GeneDx Holdings in Q4 2020 and held it in 2 quarters.
  • Pura Vida Investments's GeneDx Holdings position peaked at $2.65M in Q4 2020.
  • 136 funds tracked by Wall St. Rank held GeneDx Holdings as of Q3 2024.

Based on Pura Vida Investments's 13F filing for Q3 2024, filed 14 Nov 2024.